Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

被引：29

作者：

Riggs, McKayla J. ^{[1
]}

Pandalai, Prakash K. ^{[2
]}

Kim, Joseph ^{[2
]}

Dietrich, Charles S. ^{[1
]}

机构：

[1] Univ Kentucky, Div Gynecol Oncol, Lexington, KY 40502 USA

[2] Univ Kentucky, Div Surg Oncol, Lexington, KY 40502 USA

来源：

DIAGNOSTICS | 2020年 / 10卷 / 01期

关键词：

HIPEC; ovarian cancer; peritoneal cancer; review; technique; LONG-TERM SURVIVAL; CYTOREDUCTIVE SURGERY; PERITONEAL CARCINOMATOSIS; RANDOMIZED-TRIAL; ONCOLOGY-GROUP; HIPEC; RECURRENT; CISPLATIN; PACLITAXEL; MULTICENTER;

D O I：

10.3390/diagnostics10010043

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hyperthermic intraperitoneal chemotherapy (HIPEC) in conjunction with cytoreductive surgery (CRS) holds promise as an adjunctive treatment strategy in malignancies affecting the peritoneal surface, effectively targeting remaining microscopic residual tumor. HIPEC increases concentrations of chemotherapy directly within the peritoneal cavity compared with the intravenous route and reduces the systemic side effects associated with prolonged adjuvant intraperitoneal exposure. Furthermore, hyperthermia increases tissue penetration and is synergistic with the therapeutic chemotherapy agents used. In ovarian cancer, evidence is building for its use in both primary and recurrent scenarios. In this review, we examine the history of HIPEC, the techniques used, and the available data guiding its use in primary and recurrent ovarian cancer.

引用

页数：14

共 48 条

[1] Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer [J].

Alberts, DS ;

Liu, PY ;

Hannigan, EV ;

OToole, R ;

Williams, SD ;

Young, JA ;

Franklin, EW ;

ClarkePearson, DL ;

Malviya, VK ;

DuBeshter, B ;

Adelson, MD ;

Hoskins, WJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) :1950-1955

[2] Evaluation of Extensive Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Epithelial Ovarian Cancer [J].

Ansaloni, Luca ;

Agnoletti, Vanni ;

Amadori, Andrea ;

Catena, Fausto ;

Cavaliere, Davide ;

Coccolini, Federico ;

De Iaco, Pierandrea ;

Di Battista, Monica ;

Framarini, Massimo ;

Gazzotti, Filippo ;

Ghermandi, Claudio ;

Kopf, Barbara ;

Saponara, Maristella ;

Tauceri, Francesca ;

Vallicelli, Carlo ;

Verdecchia, Giorgio Maria ;

Pinna, Antonio Daniele .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (05) :778-785

[3] Treatment of Microscopic Disease with Hyperthermic Intraoperative Intraperitoneal Chemotherapy After Complete Cytoreduction Improves Disease-Free Survival in Patients with Stage IIIC/IV Ovarian Cancer [J].

Antonio Cascales-Campos, Pedro ;

Gil, J. ;

Gil, E. ;

Feliciangeli, E. ;

Gonzalez-Gil, A. ;

Parrilla, J. J. ;

Parrilla, P. .

ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (07) :2383-2389

[4] NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019 [J].

Armstrong, Deborah K. ;

Alvarez, Ronald D. ;

Bakkum-Gamez, Jamie N. ;

Barroilhet, Lisa ;

Behbakht, Kian ;

Berchuck, Andrew ;

Berek, Jonathan S. ;

Chen, Lee-may ;

Cristea, Mihaela ;

DeRosa, Marie ;

ElNaggar, Adam C. ;

Gershenson, David M. ;

Gray, Heidi J. ;

Hakam, Ardeshir ;

Jain, Angela ;

Leath, Charles A., III ;

Liu, Joyce ;

Mahdi, Haider ;

Matei, Daniela ;

McHale, Michael ;

McLean, Karen ;

O'Malley, David M. ;

Penson, Richard T. ;

Percac-Lima, Sanja ;

Ratner, Elena ;

Remmenga, Steven W. ;

Sabbatini, Paul ;

Werner, Theresa L. ;

Zsiros, Emese ;

Burns, Jennifer L. ;

Engh, Anita M. .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (08) :896-+

[5] Intraperitoneal cisplatin and paclitaxel in ovarian cancer [J].

Armstrong, DK ;

Bundy, B ;

Wenzel, L ;

Huang, HQ ;

Baergen, R ;

Lele, S ;

Copeland, LJ ;

Walker, JL ;

Burger, RA .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :34-43

[6] Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer [J].

Bakrin, N. ;

Classe, J. M. ;

Pomel, C. ;

Gouy, S. ;

Chene, G. ;

Glehen, O. .

JOURNAL OF VISCERAL SURGERY, 2014, 151 (05) :347-353

[7] Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: A French multicentre retrospective cohort study of 566 patients [J].

Bakrin, N. ;

Bereder, J. M. ;

Decullier, E. ;

Classe, J. M. ;

Msika, S. ;

Lorimier, G. ;

Abboud, K. ;

Meeus, P. ;

Ferron, G. ;

Quenet, F. ;

Marchal, F. ;

Gouy, S. ;

Morice, P. ;

Pomel, C. ;

Pocard, M. ;

Guyon, F. ;

Porcheron, J. ;

Glehen, O. .

EJSO, 2013, 39 (12) :1435-1443

[8] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Persistent and Recurrent Advanced Ovarian Carcinoma: A Multicenter, Prospective Study of 246 Patients [J].

Bakrin, N. ;

Cotte, E. ;

Golfier, F. ;

Gilly, F. N. ;

Freyer, G. ;

Helm, W. ;

Glehen, O. ;

Bereder, J. M. .

ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (13) :4052-4058

[9] Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer [J].

Cascales Campos, P. A. ;

Gil Martinez, J. ;

Galindo Fernandez, P. J. ;

Gil Gomez, E. ;

Martinez Frutos, I. M. ;

Parrilla Paricio, P. .

EJSO, 2011, 37 (06) :543-548

[10]

CASPER ES, 1983, CANCER TREAT REP, V67, P235

← 1 2 3 4 5 →